Burden and indirect cost of vaccine-preventable cancer mortality in Europe

• DOI: 10.1080/13696998.2024.2374684
• Publication Date: 2024-07-16T05:53:20Z
• Authors: Goran Bencina; Ugne Sabale; Edith Morais; Olga Ovcinnikova; Edward Oliver; Hayley Shoel; Anne Meiwald; Robert Hughes; Georgie Weston; Karin Sundström
• Keywords: Hepatitis B

Background The economic and mortality burden of cancer is high worldwide. In Europe, was responsible for 1.3 million deaths in 2020 incurred an estimated cost €50 billion from premature mortality. Human papillomavirus (HPV) hepatitis B virus (HBV) are among the leading causes infection-related cancers despite availability effective vaccines against these infections. This analysis productivity loss HBV- HPV-associated that could be preventable through vaccination across European regions.